ATCC offers well-characterized cells and cell derivatives that support the development and evaluation of high-throughput screening assays for the exploration of metabolic pathways and genetic variation as well as rapid assessment of pharmaceutical efficacy and compound toxicity.
Cell- and nucleic acid-based assays are widely used in drug discovery, toxicity studies, and cancer research. ATCC continuous cell lines, genomic DNA, reporter-labeled cell lines, and tumor cell panels are all established tools for screening the effects of various therapeutics, carrier agents, and environmental toxins. Additionally, ATCC has developed new products that are designed for assay development, such as an isogenic lung cancer cell line, a single-use in vitro angiogenesis assay, neural progenitor cells, and more.
Use the links below to find the resources you need. Or, contact our ATCC Sales Representative at email@example.com in the U.S. If you are an international customer, visit ATCC Distributors to find out if ATCC has an authorized distributor in your location.
Angio-Ready Assay Ready System
Angio-Ready is an assay-ready, single-use kit designed for the high-throughput monitoring of angiogenesis. This kit contains the ideal ratio of GFP-expressing hTERT-immortalized endothelial cells pre-mixed with hTERT-immortalized mesenchymal stem cells, and is supplied with complete growth medium.
Are you Angio-Ready? Choose from two available sizes:
Reporter-labeled Cell Lines
Reporter-labeled cell lines are useful for monitoring various biological functions. These cells either constitutively or inducibly expresses a reporter gene (such as GFP or luciferase). ATCC is continually accessioning and creating new reporter cell lines to quicken the pace of your research.
Reporter-labeled cell lines